Sweetser Seth, Jones Andrea, Smyrk Thomas C, Sinicrope Frank A
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.
Clin Gastroenterol Hepatol. 2016 Jul;14(7):1056-9. doi: 10.1016/j.cgh.2016.01.021. Epub 2016 Feb 17.
We investigated whether sessile serrated adenomas/polyps (SSA/Ps) are direct precursors of colorectal carcinomas. We identified colon carcinomas that arose from SSA/Ps among 2646 colorectal cancers included in the surgical pathology database at the Mayo Clinic (2006-2012). Molecular features of the serrated neoplasia pathway were analyzed in these tumors by immunohistochemical analyses of mutant BRAF (V600E) and MLH1 proteins. Among the 33 identified SSA/P-associated colonic adenocarcinomas (median patient age, 75 y), 24 developed in women (73%), 31 were located in the proximal colon (94%), and 23 (69%) were TNM stage I or II. Thirty-one of the tumors (94%) expressed mutant BRAF; of these, 26 also had loss of MLH1 (79%), indicating deficient DNA mismatch repair of sporadic origin. Twenty-two of the tumors (67%) were interval cancers that were more common in women and did not differ significantly in TNM stage, BRAF mutation, or loss of MLH1. By histopathology, SSA/Ps that were associated with colon carcinomas contained frequent dysplasia (48%). Most cancers that arose from SSA/Ps were located on the right side of the colon and had mutant BRAF and loss of MLH1. These findings indicate that SSA/Ps are precursors of most sporadic colon carcinomas with deficient DNA mismatch repair.
我们研究了无蒂锯齿状腺瘤/息肉(SSA/P)是否为结直肠癌的直接前体。我们在梅奥诊所手术病理数据库(2006 - 2012年)收录的2646例结直肠癌中,识别出源自SSA/P的结肠癌。通过对突变型BRAF(V600E)和MLH1蛋白进行免疫组化分析,研究了这些肿瘤中锯齿状肿瘤发生途径的分子特征。在33例已识别的与SSA/P相关的结肠腺癌中(患者年龄中位数为75岁),24例发生于女性(73%),31例位于近端结肠(94%),23例(69%)为TNM I期或II期。31例肿瘤(94%)表达突变型BRAF;其中26例还存在MLH1缺失(79%),表明为散发性DNA错配修复缺陷。22例肿瘤(67%)为间隔期癌,在女性中更为常见,在TNM分期、BRAF突变或MLH1缺失方面无显著差异。通过组织病理学检查,与结肠癌相关的SSA/P常伴有发育异常(48%)。大多数源自SSA/P的癌症位于结肠右侧,具有BRAF突变和MLH1缺失。这些发现表明,SSA/P是大多数伴有DNA错配修复缺陷的散发性结肠癌的前体。